Henry Schein Inc. or
HSIC continues to make significant movements in the bio-tech industry both domestically and internationally. The company launched new products, including
Dentrix Eligibility Offerings and
Henry Schein One while actively participating at international conferences such as the
FDIC World Dental Congress 2024 in Istanbul, Turkey. Despite certain downturns in stock performance, numerous ventures and partnerships across various sectors including oral health and orthopedics have bolstered its growth.
Acquisitions such as the majority stake in
TriMed, Inc. and an entry into the homecare market with the acquisition of
Shield Healthcare has further diversified its portfolio. However, the company's performance was affected by a
cyberattack, causing a reduction in the future guidance. It faced challenges with mixed Q2 earnings and sales. Multiple insider sales of HSIC shares have taken place. HSIC continues to show resiliency with its
global expansion plans, despite existing macroeconomic issues.
Henry Schein HSIC News Analytics from Mon, 11 Oct 2021 07:00:00 GMT to Sun, 15 Sep 2024 13:00:47 GMT -
Rating -2
- Innovation -4
- Information 3
- Rumor -4
